524604 — Adline Chem Lab Income Statement
0.000.00%
- IN₹99.86m
- IN₹114.11m
Annual income statement for Adline Chem Lab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IAS | IAS | IAS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 63.3 | 7.37 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 33 | 2.57 | -2.59 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 75.8 | 2.42 | 8.84 | 1.78 | 3.23 |
Operating Profit | -12.5 | 4.95 | -8.84 | -1.78 | -3.23 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.8 | 6.72 | -42.3 | -3.03 | -2.06 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.8 | 7.18 | -42.3 | -2.72 | -1.32 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.8 | 7.18 | -42.3 | -2.72 | -1.32 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.8 | 7.18 | -42.3 | -2.72 | -1.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.19 | -0.041 | 0.19 | -0.465 | -0.226 |